{
  "id": 13842683,
  "title": "Dong-A ST’s Anemia Biosimilar Darbecron Launches in the UAE",
  "url": "https://urgent.news/2026/10/12/dong-a-sts-anemia-biosimilar-darbecron-launches-in-the-uae",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-12T01:46:06.000Z",
  "source": {
    "name": "Korea IT Times",
    "slug": "korea-it-times",
    "url": "https://www.koreaittimes.com/news/articleView.html?idxno=157993"
  },
  "original_language": "en",
  "account": null,
  "summary": "Dong-A ST has launched its second-generation anemia treatment biosimilar, Darbecron, in the United Arab Emirates (UAE), marking the first commercial rollout of the product in the Middle East and North Africa (MENA) region. Developed under the project name DA-3880, the biosimilar is now available in the UAE, following local regulatory approval and commercialization handled by Julphar, a pharmaceutical company based in the UAE.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}